Back to Journals » Clinical Ophthalmology » Volume 4

Serum free fatty acids levels not associated with normal tension glaucoma

Authors Yuki K, Kimura I, Tsubota K

Published 18 February 2010 Volume 2010:4 Pages 91—94

DOI https://doi.org/10.2147/OPTH.S9418

Review by Single anonymous peer review

Peer reviewer comments 5



Kenya Yuki, Itaru Kimura, Kazuo Tsubota

Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan

Purpose: To determine the free fatty acid levels in the sera of patients with normal-tension glaucoma and compare it with that of normal controls.

Methods: Forty-four consecutive patients with newly diagnosed normal-tension glaucoma and forty-four age and gender matched controls were evaluated. The type and level of fatty acids in the sera were measured by gas chromatography (Model GC17A; Shimazu, Kyoto, Japan). Twenty-four fatty acids were identified from 12:0 to 24:1. The values were compared between the normal-tension glaucoma and control groups by Mann–Whitney U tests.

Results: No statistically significant difference was found in the levels of any free fatty acids between the normal-tension glaucoma group and control group.

Conclusion: No significant association was found in the serum free fatty acids levels including docosahexaenoic acid and eicosapentaenoic acid between normal-tension glaucoma patients and controls.

Keywords: free fatty acid, docosahexaenoic acid, eicosapentaenoic acid, normal tension glaucoma

Creative Commons License © 2010 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.